AT
IDXX icon

Avalon Trust’s Idexx Laboratories IDXX Stock Holding History

Avalon Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33.7K Sell
60
-90
-60% -$57.7K ﹤0.01% 323
2025
Q4 		$101K Hold
150
– – 0.01% 201
2025
Q3 		$95.8K Buy
150
+100
+200% +$60.7K 0.01% 237
2025
Q2 		$26.8K Hold
50
– – ﹤0.01% 308
2025
Q1 		$21K Hold
50
– – ﹤0.01% 327
2024
Q4 		$20.7K Hold
50
– – ﹤0.01% 288
2024
Q3 		$25.2K Hold
50
– – ﹤0.01% 253
2024
Q2 		$24.4K Hold
50
– – ﹤0.01% 254
2024
Q1 		$27K Hold
50
– – ﹤0.01% 253
2023
Q4 		$27.8K Hold
50
– – ﹤0.01% 245
2023
Q3 		$21.9K Hold
50
– – ﹤0.01% 227
2023
Q2 		$25.1K Hold
50
– – ﹤0.01% 243
2023
Q1 		$25K Buy
+50
New +$23.9K ﹤0.01% 232

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Avalon Trust's IDXX Position: Q1 2026 in Review

Avalon Trust reduced its Idexx Laboratories (IDXX) stake by 60% in Q1 2026, selling an estimated $57.7K and leaving 60 shares worth $33.7K. The position accounts for ﹤0.01% of the portfolio, ranked #323.

Avalon Trust first reported a position in IDXX in Q1 2023 and has held it in 13 quarters since. The position peaked at $101K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Avalon Trust held 60 shares of Idexx Laboratories worth $33.7K as of Q1 2026.
  • Avalon Trust sold 90 Idexx Laboratories shares in Q1 2026, an estimated $57.7K.
  • Idexx Laboratories made up ﹤0.01% of Avalon Trust's portfolio in Q1 2026, its #323 holding.
  • Avalon Trust first reported a position in Idexx Laboratories in Q1 2023 and has held it in 13 quarters since.
  • Avalon Trust's Idexx Laboratories position peaked at $101K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.